Comparative Effectiveness of Resection vs Surveillance for Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasms With Worrisome Features

被引:15
作者
Hu, Yinin [1 ]
Johnston, Lily E. [1 ]
Shami, Vanessa M. [2 ]
Bauer, Todd W. [1 ]
Adams, Reid B. [1 ]
Stukenborg, George J. [3 ,4 ]
Zaydfudim, Victor M. [1 ,4 ]
机构
[1] Univ Virginia, Sch Med, Dept Surg, Charlottesville, VA 22908 USA
[2] Univ Virginia, Sch Med, Dept Gastroenterol, Charlottesville, VA 22908 USA
[3] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA
[4] Univ Virginia, Sch Med, Surg Outcomes Res Ctr, Charlottesville, VA USA
关键词
QUALITY-OF-LIFE; CONSENSUS-GUIDELINES; MALIGNANT-TRANSFORMATION; SURGICAL RESECTION; COST-EFFECTIVENESS; FOLLOW-UP; MANAGEMENT; CANCER; PANCREATICODUODENECTOMY; PREDICTORS;
D O I
10.1001/jamasurg.2017.4587
中图分类号
R61 [外科手术学];
学科分类号
摘要
IMPORTANCE The 2012 international consensus guidelines defined a subcategory of pancreatic branch duct intraductal papillary mucinous neoplasms with "worrisome features," which may be followed with close surveillance. However, given the poor prognosis of invasive malignancy, the role of early, upfront resection requires further investigation. OBJECTIVE To compare the utility of upfront resection vs long-term surveillance. We hypothesized that surveillance of these cystic neoplasms would offer greater long-term utility. DESIGN, SETTING, AND PARTICIPANTS A Markov decision analysis model was constructed to estimate and compare 2 management strategies: early resection and long-term surveillance. Estimates for the utility of outcomes, probabilities of transitions between disease states, and probabilities of surgical morbidity were derived from a literature review of articles published between 1997 and 2014. The comparative effectiveness model's variable estimates were based on data published predominantly by high-volume, tertiary referral centers. Model probability variable estimates were derived from large, retrospective, single-institution reports. For utility variables, estimates derived from studies using standard-gamble or time-tradeoff methods were given greater weight. MAIN OUTCOMES AND MEASURES Expected utility was measured in terms of quality-adjusted life years using 3% annual discount. Probabilistic and 1-way sensitivity analyses were performed to assess the potential effects of uncertainty in estimates of key model variables. RESULTS Early resection yielded 11.63 quality-adjusted life-years during 20 years of follow-up compared with 11.06 for surveillance. Probabilistic sensitivity analysis indicated that resection has a 94% likelihood of being more effective than surveillance. Early resection obtained greater utility only if each of the following criteria are met: life expectancy is at least 18 years, surgical mortality is less than 4.3%, and baseline preoperative utility is at least 0.78. Additional drivers of the model outcomes include the rate of progression from worrisome to high-risk features and the likelihood of finding cancer on resection for neoplasms with high-risk stigmata. CONCLUSIONS AND RELEVANCE Early resection compares favorably with surveillance in the management of branch duct intraductal papillary mucinous neoplasms with worrisome features. However, careful consideration of patient factors and surgeon outcomes is imperative.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 50 条
  • [1] Higher Growth Rate of Branch Duct Intraductal Papillary Mucinous Neoplasms Associates With Worrisome Features
    Kolb, Jennifer M.
    Argiriadi, Pamela
    Lee, Karen
    Liu, Xiaoyu
    Bagiella, Emilia
    Gupta, Shivani
    Lucas, Aimee L.
    Kim, Michelle Kang
    Kumta, Nikhil A.
    Nagula, Satish
    Sarpel, Umut
    DiMaio, Christopher J.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (09) : 1481 - 1487
  • [2] Long-term surveillance of branch-duct intraductal papillary mucinous neoplasms without worrisome or high-risk features
    Lattimore, Courtney M. M.
    Kane, William J. J.
    Subbarao, Shalini
    Venitti, Corinne
    Cramer, Christopher L. L.
    Turkheimer, Lena M. M.
    Bauer, Todd W. W.
    Turrentine, Florence E. E.
    Zaydfudim, Victor M. M.
    JOURNAL OF SURGICAL ONCOLOGY, 2023, 128 (07) : 1087 - 1094
  • [3] Higher volume growth rate is associated with development of worrisome features in patients with branch duct-intraductal papillary mucinous neoplasms
    Innocenti, Tommaso
    Danti, Ginevra
    Lynch, Erica Nicola
    Dragoni, Gabriele
    Gottin, Matteo
    Fedeli, Filippo
    Palatresi, Daniele
    Biagini, Maria Rosa
    Milani, Stefano
    Miele, Vittorio
    Galli, Andrea
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (17) : 5667 - 5679
  • [4] Decision making for pancreatic resection in patients with intraductal papillary mucinous neoplasms
    Xu, Bin
    Ding, Wei-Xing
    Jin, Da-Yong
    Wang, Dan-Song
    Lou, Wen-Hui
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (09) : 1451 - 1457
  • [5] Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms
    Kaiser, Joerg
    Fritz, Stefan
    Klauss, Miriam
    Bergmann, Frank
    Hinz, Ulf
    Strobel, Oliver
    Schneider, Lutz
    Buehler, Markus W.
    Hackert, Thilo
    SURGERY, 2017, 161 (03) : 602 - 610
  • [6] Side-branch intraductal papillary mucinous neoplasms of the pancreatic head/uncinate: resection or enucleation?
    Turrini, Olivier
    Schmidt, C. Max
    Pitt, Henry A.
    Guiramand, Jerome
    Aguilar-Saavedra, Juan R.
    Aboudi, Shadi
    Lillemoe, Keith D.
    Delpero, Jean Robert
    HPB, 2011, 13 (02) : 126 - 131
  • [7] Pancreatic Ductal Adenocarcinomas in Long-Term Follow-Up Patients With Branch Duct Intraductal Papillary Mucinous Neoplasms
    Tanno, Satoshi
    Nakano, Yasuhiro
    Koizumi, Kazuya
    Sugiyama, Yoshiaki
    Nakamura, Kazumasa
    Sasajima, Junpei
    Nishikawa, Tomoya
    Mizukami, Yusuke
    Yanagawa, Nobuyuki
    Fujii, Tsuneshi
    Okumura, Toshikatsu
    Obara, Takeshi
    Kohgo, Yutaka
    PANCREAS, 2010, 39 (01) : 36 - 40
  • [8] Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms
    Jang, J. -Y.
    Park, T.
    Lee, S.
    Kang, M. J.
    Lee, S. Y.
    Lee, K. B.
    Chang, Y. R.
    Kim, S. -W.
    BRITISH JOURNAL OF SURGERY, 2014, 101 (06) : 686 - 692
  • [9] Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection
    Nagai, Kazumasa
    Mizukami, Yusuke
    Omori, Yuko
    Kin, Toshifumi
    Yane, Kei
    Takahashi, Kuniyuki
    Ono, Yusuke
    Sugitani, Ayumu
    Karasaki, Hidenori
    Shinohara, Toshiya
    Furukawa, Toru
    Hayashi, Tsuyoshi
    Okumura, Toshikatsu
    Maguchi, Hiroyuki
    Katanuma, Akio
    MODERN PATHOLOGY, 2020, 33 (05) : 971 - 980
  • [10] Branch duct intraductal papillary mucinous neoplasm - contra resection
    Brunner, M.
    Weber, G. F.
    Kersting, S.
    Gruetzmann, Robert
    CHIRURG, 2017, 88 (11): : 918 - 925